Floseal
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Intraoperative Bleeding
Conditions
Intraoperative Bleeding, Post-operative Bleeding
Trial Timeline
Jan 1, 2012 → Jan 1, 2017
NCT ID
NCT01891461About Floseal
Floseal is a approved stage product being developed by Baxter for Intraoperative Bleeding. The current trial status is completed. This product is registered under clinical trial identifier NCT01891461. Target conditions include Intraoperative Bleeding, Post-operative Bleeding.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01974193 | Phase 3 | UNKNOWN |
| NCT01891461 | Approved | Completed |
Competing Products
3 competing products in Intraoperative Bleeding
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| pudexacianinium chloride | Astellas Pharma | Phase 3 | 77 |
| pudexacianinium chloride | Astellas Pharma | Phase 3 | 77 |
| Rocuronium | Merck | Pre-clinical | 23 |